ursolic acid has been researched along with Experimental Neoplasms in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, S; Chen, X; Chi, T; Fan, L; Jia, L; Jiang, K; Li, T; Liu, Y; Shao, J; Zheng, G | 1 |
| Fan, L; Guo, Y; Jiang, K; Shao, JW; Shen, Z; Zhao, R; Zheng, G | 1 |
| Jiang, Z; Wu, Y; Xiong, H; Yang, M; Yao, J; Zhou, J | 1 |
| Gao, JL; He, BC; He, TC; Huang, EY; Ji, X; Jiang, W; Lv, GY; Shou, QY; Shui, YM | 1 |
| Gao, D; Li, L; Liu, L; Liu, Y; Wang, L; Wang, M; Wang, Q; Xing, S; Zhao, T | 1 |
| Kuttan, G; Raphael, TJ | 1 |
1 review(s) available for ursolic acid and Experimental Neoplasms
| Article | Year |
|---|---|
Ursolic acid liposomes with chitosan modification: Promising antitumor drug delivery and efficacy.
Topics: Animals; Antineoplastic Agents; Chitosan; HeLa Cells; Humans; Hydrogen-Ion Concentration; Liposomes; Mice; Neoplasms, Experimental; Triterpenes; Ursolic Acid; Xenograft Model Antitumor Assays | 2017 |
5 other study(ies) available for ursolic acid and Experimental Neoplasms
| Article | Year |
|---|---|
A smart pH-responsive nano-carrier as a drug delivery system for the targeted delivery of ursolic acid: suppresses cancer growth and metastasis by modulating P53/MMP-9/PTEN/CD44 mediated multiple signaling pathways.
Topics: Animals; Apoptosis; Cell Cycle Checkpoints; Cell Movement; Chitosan; Drug Delivery Systems; Folic Acid; HeLa Cells; Hep G2 Cells; Humans; Hyaluronan Receptors; Hydrogen-Ion Concentration; Matrix Metalloproteinase 9; Mice; Mice, Nude; Nanoparticles; Neoplasms, Experimental; Poly (ADP-Ribose) Polymerase-1; Proto-Oncogene Proteins c-bcl-2; PTEN Phosphohydrolase; Signal Transduction; Triterpenes; Tumor Suppressor Protein p53; Ursolic Acid | 2017 |
Carrier-free nanodrug by co-assembly of chemotherapeutic agent and photosensitizer for cancer imaging and chemo-photo combination therapy.
Topics: Animals; Asialoglycoprotein Receptor; HeLa Cells; Hep G2 Cells; Humans; Hyperthermia, Induced; Male; Mice; Neoplasm Proteins; Neoplasms, Experimental; Optical Imaging; Photochemotherapy; Reactive Oxygen Species; Triterpenes; Ursolic Acid; Xenograft Model Antitumor Assays | 2018 |
pH-activatable polymeric nanodrugs enhanced tumor chemo/antiangiogenic combination therapy through improving targeting drug release.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Cell Proliferation; Cell Survival; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Liberation; Drug Screening Assays, Antitumor; Hep G2 Cells; Heparin; Humans; Hydrogen-Ion Concentration; Mice; Mice, Inbred BALB C; Nanoparticles; Neoplasms, Experimental; Neovascularization, Pathologic; Particle Size; Polymers; Structure-Activity Relationship; Surface Properties; Triterpenes; Tumor Cells, Cultured; Ursolic Acid | 2019 |
Hypoxia pathway and hypoxia-mediated extensive extramedullary hematopoiesis are involved in ursolic acid's anti-metastatic effect in 4T1 tumor bearing mice.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Female; Hematopoiesis, Extramedullary; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Lung Neoplasms; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Neovascularization, Pathologic; Signal Transduction; Triterpenes; Ursolic Acid; Von Hippel-Lindau Tumor Suppressor Protein | 2016 |
Effect of naturally occurring triterpenoids ursolic acid and glycyrrhizic acid on the cell-mediated immune responses of metastatic tumor-bearing animals.
Topics: Animals; Anti-Inflammatory Agents; Antibody-Dependent Cell Cytotoxicity; Glycyrrhizic Acid; Interleukin-2; Male; Mice; Neoplasm Metastasis; Neoplasms, Experimental; Triterpenes; Ursolic Acid | 2008 |